scPharmaceuticals Inc. (SCPH): Price and Financial Metrics

scPharmaceuticals Inc. (SCPH): $3.51

0.01 (-0.28%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

SCPH Price/Volume Stats

Current price $3.51 52-week high $11.75
Prev. close $3.52 52-week low $3.24
Day low $3.39 Volume 370,100
Day high $3.79 Avg. volume 234,377
50-day MA $4.72 Dividend yield N/A
200-day MA $5.77 Market Cap 126.55M

SCPH Stock Price Chart Interactive Chart >


scPharmaceuticals Inc. (SCPH) Company Bio


scPharmaceuticals Inc. engages in the development and commercialization of transformative pharmaceutical products. The company’s under development products are for heart failure and infectious diseases that include Furoscix that is for treatment of worsening or decompensated heart failure outside of the inpatient setting. scPharmaceuticals Inc. formerly known as scPharmaceuticals LLC. and changed its name to scPharmaceuticals Inc. in March 2014. The company was founded 2013 and is based in Burlington, Massachusetts.


SCPH Latest News Stream


Event/Time News Detail
Loading, please wait...

SCPH Latest Social Stream


Loading social stream, please wait...

View Full SCPH Social Stream

Latest SCPH News From Around the Web

Below are the latest news stories about SCPHARMACEUTICALS INC that investors may wish to consider to help them evaluate SCPH as an investment opportunity.

scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcript

scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcript November 8, 2023 scPharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.36. Operator: Thank you for standing by. This is the conference operator. Welcome to the scPharmaceuticals Third Quarter 2023 Earnings Conference Call. As a reminder, all participants are in listen-only mode […]

Yahoo | November 9, 2023

scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

Generated net FUROSCIX® revenue of $3.8 million Ended Q3 2023 with cash, cash equivalents and short-term investments of $90.2 million Company to host investor conference call and webcast today, Wednesday, November 8, at 4:30pm ET BURLINGTON, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduc

Yahoo | November 8, 2023

scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

Management to host conference call and webcast at 4:30 p.m. ETBURLINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, November 8, 2023, to discuss the financial res

Yahoo | November 1, 2023

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

BURLINGTON, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, will participate in two upcoming investor conferences. Event: Jefferies London Healthcare ConferenceTuesday, November 14, 2023Fireside chat

Yahoo | October 31, 2023

Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 47%

While scPharmaceuticals Inc. ( NASDAQ:SCPH ) shareholders are probably generally happy, the stock hasn't had...

Yahoo | October 19, 2023

Read More 'SCPH' Stories Here

SCPH Price Returns

1-mo -19.31%
3-mo -37.99%
6-mo -36.18%
1-year -66.79%
3-year -38.53%
5-year -1.68%
YTD -44.02%
2023 -12.55%
2022 42.83%
2021 -5.10%
2020 -6.54%
2019 50.53%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!